Aqueous solution for intravenous administration

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4327084
SERIAL NO

06088651

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Clear aqueous solution capable for intravenous administration comprising 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidine as a sulphonamide potentiator, a water-soluble medicinally-acceptable salt of 3-methoxy-4-(4'-aminobenzol-sulphonamido)-1,2,5-thiadiazole and from about 5 to about 40% by weight of a compound selected from the group consisting of sugar-alcohols having 5 or 6 carbon atoms, glucose and fructose, which solution has a pH-value within the range of 6 to 8.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • HAFSLUND NYCOMED PHARMA AKTIENGESELLSCHAFT;CHEMIE HOLDING AKTIENGESELLSCHAFT

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Groke, Karl Eggersdorf, AT 7 63

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation